Lack of association of Toll-like receptor 9 polymorphisms with susceptibility to systemic lupus erythematosus in an Asian population: a meta-analysis

References

• Kim WU, Sreih A, Bucala R. Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention. Autoimmun Rev. 2009;8:204–8.
   Google Scholar
• Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335–76.
   PubMed Web of Science ®Google Scholar
• Hendrich B, Tweedie S. The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet. 2003;19:269–77.
   PubMed Web of Science ®Google Scholar
• Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci USA. 1996;93: 2879–83.
   Google Scholar
• Du X, Poltorak A, Wei Y, Beutler B. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw. 2000;11:362–71.
   PubMed Web of Science ®Google Scholar
• Lafyatis R, Marshak-Rothstein A. Toll-like receptors and innate immune responses in systemic lupus erythematosus. Arthritis Res Ther. 2007;9:222.
   PubMed Web of Science ®Google Scholar
• Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, et al. Expansion of toll-like receptor 9-express-ing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum. 2006;54:3601–11.
   PubMed Web of Science ®Google Scholar
• Nakano S, Morimoto S, Suzuki J, Nozawa K, Amano H, Tokano Y, et al. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus. Rheumatology (Oxford). 2008;47:145–9.
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of sys-temic lupus erythematosus. Arthritis Rheum. 1982;25:1271–7.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythe-matosus. Arthritis Rheum. 1997;40:1725.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–8.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–8.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315:629–34.
   PubMed Web of Science ®Google Scholar
• Hur JW, Shin HD, Park BL, Kim LH, Kim SY, Bae SC. Asso-ciation study of Toll-like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus. Tissue Antigens. 2005;65:266–70.
   PubMed Web of Science ®Google Scholar
• Ng MW, Lau CS, Chan TM, Wong WH, Lau YL. Polymorphisms of the toll-like receptor 9 (TLR9) gene with systemic lupus ery-thematosus in Chinese. Rheumatology (Oxford). 2005;44: 1456–7.
   Google Scholar
• De Jager PL, Richardson A, Vyse TJ, Rioux JD. Genetic variation in toll-like receptor 9 and susceptibility to systemic lupus ery-thematosus. Arthritis Rheum. 2006;54:1279–82.
   PubMed Web of Science ®Google Scholar
• Tao K, Fujii M, Tsukumo S, Maekawa Y, Kishihara K, Kimoto Y, et al. Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis. 2007;66:905–9.
   PubMed Web of Science ®Google Scholar
• Demirci FY, Manzi S, Ramsey-Goldman R, Kenney M, Shaw PS, Dunlop-Thomas CM, et al. Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymor-phisms in systemic lupus erythematosus. J Rheumatol. 2007;34: 1708–11.
   Google Scholar
• Youinou P. Do Toll-like receptors contribute to the pathogenesis of lupus? J Rheumatol. 2007;34:1641-2.
   Google Scholar
• Yu P, Musette P, Peng SL. Toll-like receptor 9 in murine lupus: more friend than foe! Immunobiology. 2008;213: 151–7.
   Google Scholar
• Akahoshi M, Nakashima H, Sadanaga A, Miyake K, Obara K, Tamari M, et al. Promoter polymorphisms in the IRF3 gene confer protection against systemic lupus erythematosus. Lupus. 2008;17:568–74.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Roelens I, Lauwerys BR. Genetic susceptibility to autoimmune disorders: clues from gene association and gene expression studies. Curr Mol Med. 2008;8:551–61.
   Google Scholar
• Xu CJ, Zhang WH, Pan HF, Li XP, Xu JH, Ye DQ. Association study of a single nucleotide polymorphism in the exon 2 region of toll-like receptor 9 (TLR9) gene with susceptibility to systemic lupus erythematosus among Chinese. Mol Biol Rep. 2009;36: 2245–8.
   PubMed Web of Science ®Google Scholar
• Graham RR, Hom G, Ortmann W, Behrens TW. Review of recent genome-wide association scans in lupus. J Intern Med. 2009;265:680–8.
   PubMed Web of Science ®Google Scholar
• Song WQ, Li HH, Chen HB, Yuan JS, Yin XI. Relationship between polymorphism sites of IRF5, TLR-9 and SLE patients in Shandong Han population. Zhonghua Yi Xue Za Zhi. 2009;89:3038-42 (in Chinese).
   Google Scholar
• Thou XJ, Lv JC, Cheng WR, Yu L, Zhao MH, Zhang H. Asso-ciation of TLR9 gene polymorphisms with lupus nephritis in a Chinese Han population. Clin Exp Rheumatol. 2010;28:397–400.
   PubMedGoogle Scholar
• Liao WL, Chen RH, Lin HJ, Liu YH, Chen WC, Tsai Y, et al. Toll-like receptor gene polymorphisms are associated with sus-ceptibility to Graves' ophthalmopathy in Taiwan males. BMC Med Genet. 2010;11:154.
   PubMed Web of Science ®Google Scholar
• Huang CM, Huang PH, Chen CL, Lin YJ, Tsai CH, Huang WL, et al. Association of toll-like receptor 9 gene polymorphism in Chinese patients with systemic lupus erythematosus in Taiwan. Rheumatol Int. 2011 (Epub ahead of print).
   Google Scholar
• Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345:340–50.
   PubMed Web of Science ®Google Scholar
• Hemmi H, Takeuchi 0, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000;408:740–5.
   Google Scholar
• Boule MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, Rifkin IR. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G com-plexes. J Exp Med. 2004;199: 1631–40.
   Google Scholar
• Means TK, Latz E, Hayashi F, Murali MR, Golenbock DT, Luster AD. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR-9. J Clin Invest. 2005;115:407–17.
   PubMed Web of Science ®Google Scholar
• Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends Genet. 2004;20:439–44.
   PubMed Web of Science ®Google Scholar